Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL490836 | 0.97 | — | — | |
| SCHEMBL9859203 | 0.83 | CA2 (0.39) | CA1CA2ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL27857308 | 0.81 | CA2 (0.37) | CA1CA2ALDH1A1 | |
| SCHEMBL778781 | 0.81 | CA1 (0.50) | CA1CA2ALDH1A1 | |
| SCHEMBL8519026 | 0.79 | CA12 (0.31) | CA1CA2 | |
| SCHEMBL21808780 | 0.79 | CA1 (0.43) | CA1CA2 | |
| SCHEMBL28363466 | 0.78 | CA1 (0.46) | CA1CA2 | |
| Ammonia Solution, Strong SCHEMBL27967329 | 0.76 | CA1 (0.44) | CA1CA2 | |
| SCHEMBL3259688 | 0.76 | CA1 (0.50) | CA1CA2ALDH1A1 | |
| SCHEMBL778055 | 0.76 | CA1 (0.46) | CA1CA2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8580723-B2 | Process compositions and production of acyl alkylisethionate compositions | HUNTSMAN PETROCHEMICAL LLC (US) | 2013-11-12 | — | — | US | claimed |
| US-20120094890-A1 | Process Compositions and Production of Acyl Alkylisethionate Compositions | HUNTSMAN PETROCHEMICAL LLC (US) | 2012-04-19 | — | — | US | claimed |
| EP-2021445-A2 | PROCESS COMPOSITIONS AND PRODUCTION OF ACYL ALKYLISETHIONATE COMPOSITIONS | Huntsman Petrochemical Corporation (US) | 2009-02-11 | — | — | EP | claimed |
| WO-2007130390-A2 | PROCESS COMPOSITIONS AND PRODUCTION OF ACYL ALKYLISETHIONATE COMPOSITIONS | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2007-11-15 | — | — | WO | claimed |
| EP-1706476-B1 | NOVEL ACYLALKYLISETHIONATE ESTERS AND APPLICATIONS IN CONSUMER PRODUCTS | HUNTSMAN PETROCHEMICAL LLC (US) | 2018-01-10 | — | — | EP | disclosed |
| US-9598358-B2 | Acylalkylisethionate esters and applications in consumer products | HUNTSMAN PETROCHEMICAL LLC (US) | 2017-03-21 | — | — | US | disclosed |
| CN-103288686-B | The preparation of acyl isethionate ester composition and production method | HUNTSMAN SPEC CHEM CORP. (US) | 2015-11-18 | — | — | CN | disclosed |
| US-8580723-B2 | Process compositions and production of acyl alkylisethionate compositions | HUNTSMAN PETROCHEMICAL LLC (US) | 2013-11-12 | — | — | US | disclosed |
| EP-2021445-B1 | PROCESS COMPOSITIONS AND PRODUCTION OF ACYL ALKYLISETHIONATE COMPOSITIONS | HUNTSMAN PETROCHEMICAL LLC (US) | 2013-10-02 | — | — | EP | disclosed |
| CN-103288686-A | Preparation and production method of acyl alkyl isethionate composition | HUNTSMAN SPEC CHEM CORP | 2013-09-11 | — | — | CN | disclosed |
| CN-101466819-B | Process for preparing acylalkylisethionate ester compositions and process for producing same | HUNTSMAN SPEC CHEM CORP | 2013-05-01 | — | — | CN | disclosed |
| US-20120094890-A1 | Process Compositions and Production of Acyl Alkylisethionate Compositions | HUNTSMAN PETROCHEMICAL LLC (US) | 2012-04-19 | — | — | US | disclosed |
| US-8008239-B2 | reacting bisulfites with alkylene oxides to form alkyl-substituted hydroxyalkyl sulfonates, which react with carboxylic acids under esterification conditions to form acylalkylisethionate esters, used as cleaning compounds | HUNTSMAN PETROCHEMICAL LLC (US) | 2011-08-30 | — | — | US | disclosed |
| US-20100215610-A1 | PROCESS COMPOSITIONS AND PRODUCTION OF ACYL ALKYLISETHIONATE COMPOSITIONS | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2010-08-26 | — | — | US | disclosed |
| CN-101466819-A | Process for preparing acylalkylisethionate ester compositions and process for producing same | HUNTSMAN SPEC CHEM CORP (US) | 2009-06-24 | — | — | CN | disclosed |
| EP-2021445-A2 | PROCESS COMPOSITIONS AND PRODUCTION OF ACYL ALKYLISETHIONATE COMPOSITIONS | Huntsman Petrochemical Corporation (US) | 2009-02-11 | — | — | EP | disclosed |
| US-20080234159-A1 | Novel Acylalkylisethionate Esters and Applications in Consumer Products | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2008-09-25 | — | — | US | disclosed |
| WO-2007130390-A2 | PROCESS COMPOSITIONS AND PRODUCTION OF ACYL ALKYLISETHIONATE COMPOSITIONS | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2007-11-15 | — | — | WO | disclosed |
| EP-1706476-A1 | NOVEL ACYLALKYLISETHIONATE ESTERS AND APPLICATIONS IN CONSUMER PRODUCTS | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2006-10-04 | — | — | EP | disclosed |
| WO-2005075623-A1 | NOVEL ACYLALKYLISETHIONATE ESTERS AND APPLICATIONS IN CONSUMER PRODUCTS | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2005-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100215610-A1 | PROCESS COMPOSITIONS AND PRODUCTION OF ACYL ALKYLISETHIONATE COMPOSITIONS | FADS1, ABHD5, AGPAT5 | CA1 3341/4885CA2 2837/4885ALDH1A1 1386/4885 |
| US-20080234159-A1 | Novel Acylalkylisethionate Esters and Applications in Consumer Products | ABHD5, AGPAT5, FADS1 | CA1 4746/4885CA2 4208/4885ALDH1A1 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.